Looking for it to hold its support around 1.15 and will enter a trade around the 1.20 zone if it closes above it with a good technical setup. I will either close my position at the 5% mark or will scale some there to hold for a longer run if the potential exists. (Not financial advice)
Shares of Clovis Oncology, Inc. CLVS rallied 19.4% on Jun 15 after management reported initial data from the phase I/II LuMIERE study on FAP-2286, which demonstrates preliminary evidence of activity as a treatment and imaging agent across a wide range of solid tumors.
Shares of Clovis Oncology, Inc. CLVS rallied 19.4% on Jun 15 after management reported initial data from the phase I/II LuMIERE study on FAP-2286, which demonstrates preliminary evidence of activity as a treatment and imaging agent across a wide range of solid tumors.
Komen:
CLVS exceeded my expectations with a strong volume today. Although it is worth a watch for consolidation it is important not to get burnt on this rocket up